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Incontinentia Pigmenti (IP) (Bloch_Sulzberg syndrome) is a rare  neurocutaneous 
syndrome characterized by multisystemic involvement that is prenatally lethal 
in the majority of affected males and shows great clinical variability when 
expressed in women. The diagnosis of IP is performed based on clinical features 
and the family history with the support of histological findings.
We report a 10-day-old female neonate with typical skin lesions and frequent 
seizure. Skin biopsy showed second stage IP.
Keywords: Incontinentia Pigmenti, Neonatal seizure, female neonate.
Introduction
Incontinentia pigmenti (IP) is an X-linked neurocutaneous syndrome with neurologic, 
ophthalmologic and dental manifestations.  Garrod reported the first probable case 
and described it as a peculiar pigmentation of skin in an infant (1).
His patient was a 2-year-old mentally retarded spastic diplegic girl who had a 
whorled pattern of brown skin pigmentation on her trunk and limbs (1,2)
Subsequently, Bloch and Sulzberger reported the condition in 1926 and 1928 as 
a clinical syndrome with constellation of features including typical cutaneous 
manifestation (1).
The disorder is a rare X-linked dominant genodermatosis (3,4,5,6). 
Up until 1987, only 700 cases were reported in the literature (1).
Carney (1976) found 653 cases in the literature (593 females, 16 males and 44 of 
unspecified sex) (7).
IP has a worldwide distribution and appears to be more common among Caucasians 
(3).
IP is an X-linked dominant male lethal syndrome. More than 95% of the reported 
cases are females, the few male being probably the result of spontaneous mutations 
and mosaicism of the X chromosome (8).
IP is caused by mutations in the NEMO/IKK-gamma gene (1,2,3,4,5).
The skin changes are often present at birth, usually develop before the end of the 
first week and rarely appear after the first two months. Three clinical stages are 
recognized:
1) Bullae 2) Papular and warty lesions   3) Pigmentation (8) 
In over half of the reported cases, organs other than skin have also been involved. 
Dental defects are frequent (8), up to 80%, and persist throughout the life (6).
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Ocular defects are found in 30% of the cases. Many 
patients may become blind (7) but more than 90% have 
normal vision (6).
CNS manifestations occur in about 25% of the cases (8) 
and include mental retardation, slow motor development, 
spastic tetraplegia and diplegia, microcephaly and 
epilepsy (1). Microcephaly and hydrocephaly have been 
also reported (2). Skeletal abnormalities are less common 
and usually minor (8).
The diagnosis of IP is made based on clinical features 
and family the history with the support of histological 
findings (5).
Usually, no treatment is necessary other than the control 
of secondary infection. Family counseling should be 
offered (1,8).
Case report 
A 10- day-old female neonate was admitted to the 
emergency ward of Ekbatan H ospital, Hamedan, because 
of skin lesions (Figure 1).
The skin lesions were erythematous linear streaks on 
the legs and trunk which appeared from three days 
before visiting. There were no more findings on physical 
examination. She was the first child and her parents 
were not consanguine. There were no similar cases in 
her family. On examination, the first episode of seizure 
occurred. She was admitted to the NICU and diagnostic 
evaluations and anti- convulsive therapy started. The 
most important laboratory finding was eosinophilia. 
Seizure occurred frequently in spite of treatment with 
Phenobarbital; therefore, phenytoin was added to the 
regimen. 
 
Figure 1. Erythematus lesions (on admission)
According to typical skin lesions and seizure, the 
diagnosis of IP was considered. Consultation with 
a dermatologist supported the diagnosis. Brain CT 
scan and ophthalmologic examinations were normal. 
EEG had a mild abnormal pattern. Finally, the patient 
was discharged with Phenobarbital. Skin biopsy was 
performed by a dermatologist after one month and 
was reported to be consistent with the second stage of 
Incontinentia Pigmenti. She was visited monthly for six 
months. Her skin lesions changed to warty lesions (figure 
2) and then to hyperpigmented lesions (figure 3)
Figure 2. warty lesions (at one month of age)
Figure 3. Hyperpigmented lesions (at six month of age)
The neurologic development was good until 6 months 
of age.
Discussion
Incontinentia pigmenti (IP) is one of the group of gene-
linked diseases known as neurocutaneous disorders. This 
rare hereditary multisystem ectodermal disorder features 
dermatologic, dental and ocular abnormalities (6).
We report this case to emphasize that in neonates 
with seizure and skin lesions, this diagnosis should be 
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considered although it is a rare syndrome.  
Most pedigrees are small, but from the accumulated 
genetic data it appears that this syndrome is due to an X-
linked dominate trait that is usually lethal in males.
More than 95% of the reported cases are females (8). 
Our case was a female, too.
Familial IP is caused by mutations in the NEMO gene 
and is referred to as IP2 or classical IP. Sporadic IP, the 
so called IP1, which maps to XP11, is categorized as 
hypomelanosis of Ito (7).
Histologically, the deposits of melanin pigment are seen 
in the corium.  The designation was based on the idea 
that the basal layer of the epidermis is incontinent of 
melanin (7,9).
IP is divided into 4 stages, which frequently overlap 
or appear together. During the first stage, which is 
between birth and 6 months of age, there is inflammation 
accompanied by skin redness and spiral lines of small 
fluid-filled blisters.
The second stage gradually develops with rough warty 
skin growths which appear on the arms or legs and 
sometimes on the head or trunk. These growths, which 
are often arranged in the same spiral or linear pattern 
as in the first stage, usually resolve during infancy or 
early childhood. The third stage begins between 3 
months and 3 years of age and is characterized by 
discoloration appearing in unusual patterns. The third 
stage is the hallmark of IP. The fourth stage consists of 
diminished pigmentation or atrophy in areas of previous 
discoloration (1,2,3,4,5,6,7). The skin changes are often 
present at birth, usually develop before the end of the 
first week and rarely appear after the first two months 
(7).
Our patient was a 10-day-old girl with erythematous 
skin lesions from 3-4 days before admission.
The pigmentation, ranging in color from blue-gray to slate 
brown, is characteristic of the syndrome and its bizarre 
splashed linear or Chinese figure and its distribution are 
diagnostic (8).
We referred the patient to a dermatologist and skin biopsy 
from the lesion was done. The result was reported as the 
second stage of Incontinentia Pigmenti.
Peripheral eosinophilia, up to 50%, is usual when acute 
inflammatory skin changes are present. There is evidence 
of both neutrophil and lymphocyte dysfunction, and 
altered immunological reactivity is observed in some 
patients (8).
  In the first CBC of our patient, eosinophilia (12%) was 
detected.
Involvement of other organs in over half of the reported 
cases are seen including dental and ocular defects, and 
CNS and skeletal abnormalities (1,2,3,5,6,7,8).
Neurologic complications occur in up to 30% of the 
patients (10). Seizure are the most common neurologic 
complication (1,8). MRI discloses a variety of 
abnormalities. These include hypoplasia of the corpous 
callosum, neuronal heterotopias and small or large vessel 
occlusion (10).
Our patient had refractory seizures that were finally 
controlled with phenobarbital and phenytoin. Neurologic 
complications may result in part from vaso-occlusive 
ischemic events (1). Other neuro-developmental 
manifestations include neurodevelopmental delay, 
spastic paralysis, microcephaly, and cerebral edema 
(1,7).
The brain CT scan of our patient was normal and 
development up to 6 month of life was also intact. 
Skin lesions were hyperpigmented at 6 months of age 
(Figure 3). Ophthalmologic examination was normal. 
No treatment is usually necessary other than the control 
of secondary infection (2,7,8,11). Systemic therapy with 
corticosteroid or sulfapyridine is usually unsuccessful 
(7).
Morbidity and mortality are related to neurologic and 
ophthalmologic sequelae (1).
The prognosis of IP is generally good (1).
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